Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Baxter International (NY:BAX)

19.45 +0.42 (+2.21%)
Streaming Delayed Price Updated: 9:40 AM EDT, May 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Baxter International

< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
25 26 Next >
News headline image
(BAX) - Analyzing Baxter Intl's Short Interest ↗
 
Via Benzinga
News headline image
Baxter Secures FDA Approval of Clinolipid (Lipid Injectable Emulsion) Neonatal and Pediatric Indication
From Baxter International Inc.
Via Business Wire
News headline image
A Glimpse Into The Expert Outlook On Baxter Intl Through 4 Analysts ↗
 
Via Benzinga
News headline image
Baxter to Present at Bank of America 2024 Health Care Conference
From Baxter International Inc.
Via Business Wire
News headline image
3 Dividend Stocks For 10%+ Annual Returns ↗
Buying undervalued dividend stocks with growth potential could lead to above-average returns. 
Via Talk Markets
News headline image
Assessing Baxter Intl: Insights From 4 Financial Analysts ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 8, 2024 ↗
Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million. 
Via Benzinga
Baxter International Inc. (NYSE: BAX) Highlighted for Surprising Price Action
Via Investor Brand Network
News headline image
Baxter Declares Quarterly Dividend
From Baxter International Inc.
Via Business Wire
News headline image
Why Is Nuvo Group (NUVO) Stock Up 200% Today? ↗
Although prenatal care specialist Nuvo Group saw its shares soar on Monday, NUVO stock faces skepticism over its SPAC merger. 
Via InvestorPlace
News headline image
The Big Split: 3 Stock Spinoffs Are Coming. Should You Buy? ↗
Stock spinoffs can unlock shareholder value but management sometimes uses them to get rid of unwanted, slow-growing businesses. 
Via InvestorPlace
News headline image
Why Is Medical Device Maker Baxter Stock Trading Lower On Thursday? ↗
Baxter reports Q1 adjusted EPS at $0.65, up 10% Y/Y, surpassing expectations. Sales hit $3.59 billion, with 2% growth on a reported basis. 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
BAX Stock Earnings: Baxter Intl Beats EPS, Beats Revenue for Q1 2024 ↗
BAX stock results show that Baxter Intl beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Baxter Reports First-Quarter 2024 Results
From Baxter International Inc.
Via Business Wire
News headline image
Baxter to Host First-Quarter 2024 Financial Results Conference Call for Investors
From Baxter International Inc.
Via Business Wire
News headline image
Medical Devices Giant Baxter Secures FDA Approval For New Infusion Pump System ↗
FDA clears Baxter's Novum IQ LVP & SYR infusion pumps with Dose IQ Safety Software, streamlining training & reducing cognitive burden. Explore enhanced safety features & EMR interoperability. 
Via Benzinga
News headline image
Baxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy
From Baxter International Inc.
Via Business Wire
News headline image
Baxter to Host Annual Meeting of Stockholders in Virtual Format
From Baxter International Inc.
Via Business Wire
News headline image
Becton, Dickinson And Co. Dividend Stock Analysis ↗
Becton, Dickinson, and Co. provides a wide range of medical devices and diagnostic products used in hospitals, doctors' offices, research labs, and other settings. 
Via Talk Markets
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Why Are Dialysis Provider Stocks Trading Higher On Tuesday? ↗
Novo Nordisk's FLOW trial reveals a 24% reduction in kidney disease progression, cardiovascular events, and death with semaglutide 1.0 mg compared to placebo. Impact on dialysis stocks 
Via Benzinga
News headline image
Baxter to Present at Raymond James 45th Annual Institutional Investors Conference
From Baxter International Inc.
Via Business Wire
News headline image
Stock Market Commentary: “Volumes Are The Name Of The Game…” ↗
Short, intermediate, and long term outlook on the market. Plus, a deep dive into our thesis on Cooper Standard 
Via Talk Markets
News headline image
Baxter Declares Quarterly Dividend
From Baxter International Inc.
Via Business Wire
News headline image
Barclays Maintains Overweight Rating for Baxter Intl: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Baxter Says 2023 Performance Reflects Strategic Initiatives With New Operating Model Without BioPharma Solutions Unit ↗
Baxter's Q4 2023 results: $3.89 billion revenue, surpassing consensus, 4% Y/Y growth. Strong sales in Medical Products, Therapies, Kidney Care, and Pharmaceuticals segments. 
Via Benzinga
News headline image
Baxter Reports Fourth-Quarter and Full-Year 2023 Results
From Baxter International Inc.
Via Business Wire
News headline image
Top Picks 2024: Baxter International ↗
Baxter International (BAX) has four divisions: Medical Products & Therapies, Healthcare Systems & Technologies, Pharmaceuticals, and Kidney Care. The stock aggressively sold off ~65% 
Via Talk Markets
News headline image
Baxter to Host Fourth-Quarter 2023 Financial Results Conference Call for Investors
From Baxter International Inc.
Via Business Wire
< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
25 26 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.